Our study demonstrates a novel mechanism that involves cooperation between EP300 and p53 and explains differences in expression of ABC family transporters between non-resistant and cisplatin-resistant NSCLC and TNBC cells. This evidence concerns the gene EP300 and non-small cell lung carcinoma.